Open Label Extension Study of PREOS



Status:Completed
Conditions:Osteoporosis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:45 - Any
Updated:4/21/2016
Start Date:October 2001
End Date:April 2005

Use our guide to learn which trials are right for you!

An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)

This is an Open Label Extension Study (OLES) for patients who participated in the 18 month
double-blind, placebo-controlled, Phase III trial (Protocol ALX1 11 93001 the TOP Study)
studying the effect of ALX1-11, recombinant human parathyroid hormone, rhPTH(1-84), on
vertebral fracture incidence. The primary objective of this study is to evaluate the safety
of continued dosing with ALX1-11, up to a maximum of 24 months, in postmenopausal
osteoporotic women who participated in Protocol ALX1 11 93001.

Effects of ALX1-11 on bone mineral density (BMD) have been documented in a dose-finding
Phase II clinical trial in osteoporotic postmenopausal women, supplemented with calcium and
Vitamin D3 but without any other treatment for osteoporosis. The anabolic effects of ALX1-11
in the lumbar vertebrae were statistically significant after the 12-month treatment period
and more pronounced than any approved therapy. Additionally, animal studies have shown that
the new bone formed by treatment with ALX1 11 is of good quality both histologically and
biomechanically.

The primary objective of this OLES is to evaluate the safety of continued dosing with
ALX1-11, up to a maximum of 24 months, in postmenopausal osteoporotic women who participated
in Protocol ALX1-11-93001. A secondary objective is to assess the change in vertebral BMD
and compare the changes observed in patients who received ALX1-11 or placebo in Protocol
ALX1-11-93001.

Patients will receive 100 µg/day of ALX1-11 daily via subcutaneous injection in this study.
Patients should continue the study drug dosing frequency they were following at the end of
Protocol ALX1-11-93001.

To enhance their safety, all patients will continue to take their daily supplements of 700
mg calcium and 400 IU Vitamin D3 prior to and during this OLES. Patients whose calcium
supplement was discontinued during Protocol ALX1-11-93001 should maintain that
discontinuation during this OLES. However upon completion of ALX1-11 dosing in the OLES,
oral calcium supplement at a dose of 700 mg each morning should be restarted and maintained
for the remainder of the OLES. Additional supplemental calcium and/or Vitamin D3 will not be
permitted. A daily multivitamin supplement may be taken during the study. However, the
multivitamin must contain no more than 200 mg/day calcium and 400 IU/day Vitamin D3.
Patients will be monitored for the development of hypercalcemia and/or hypercalciuria and
managed as described in Appendices 4 and 5.

There will be a stopping rule in this OLES. Any patient who reaches a BMD T score of -0.5 or
above, at the site or sites (vertebral, total hip, or femoral neck) that were used in the
qualification of the patient for Protocol ALX1 11-93001, will stop ALX1-11 treatment. The
patient must continue on calcium and Vitamin D3 and be followed for the remainder of this
18-month OLES. At the time of discontinuation, the patient must complete the Month 18
evaluations (Appendix 1A or 1B).

The Clinical Advisory Board (CAB) used in Protocol ALX1-11-93001 will be involved in
reviewing any patient issues that arise in this OLES. This group will provide not only
continuity of care for all the patients, but also enhanced and consistent safety monitoring
for patients participating in the OLES.

Inclusion Criteria:

- Women who completed 18 months of treatment in Protocol ALX1-11-93001; or

- Women prematurely discontinued from Protocol ALX1-11-93001 who want to participate in
OLES for the events listed below must have their clinical course reviewed and
approved by the CAB for enrollment into the OLES:

- Clinical or incident lumbar vertebral fractures as assessed by the central
imaging organization

- Clinical or incident hip fracture

- Confirmed bone loss at A/P lumbar vertebra or total hip or femoral neck as
assessed by the central imaging organization

- Body weight below 40 kg

- Development of an exclusion criterion in Protocol ALX1-11-93001

- It must be accepted by patients whose clinical courses are reviewed by the CAB that
participation in OLES may require additional tests at baseline and/or during the
study to ensure their utmost safety.

- Women with the ability to self-administer a daily injection or have a designee who
will give the injections;

- Women who are capable of understanding and giving written, voluntary informed consent
before the start of open-label dosing with ALX1-11.

Exclusion Criteria:

A. History or Concurrent Illness:

Disorders of Immunity Endocrine system Gastrointestinal system Kidney and collecting
system Liver, biliary tract and pancreatic systems Musculoskeletal system

- Patients with chronic, active joint disease requiring more than one intra-articular
injection every 6 months Neoplasia

- Patients who have had squamous or basal cell carcinoma of the skin may enter this
study if:

1. The lesion(s) were fully resected with clear margins described in a written
report by a pathologist, and

2. The patient has had no recurrence of lesions for at least one year from the time
of the original resection.

Nervous system Vascular, respiratory and cardiac system *Significant diseases or
disorders are determined by history, physical exam or laboratory tests and
judged by the Principal Investigator to be significant.

B. Concurrent Medication:

Patients may not use any of the following therapies while they are enrolled in
this OLES without permission from the Sponsor and the PMO:

- Tetracycline antibiotics for four weeks prior to bone biopsy

- Any PTH analogs [e.g., rhPTH(1-84), PTH(1-34), PTHrP and analogs]

- Fluoride

- Strontium

- Phenytoin for seizure control

- Any investigational drug other than ALX1-11

- Anabolic steroids or androgens

- Active Vitamin D3 metabolites and analogs, e.g., calcitriol

- Systemic corticosteroids, more than 5 mg/day prednisone or a systemic
corticosteroid formulation equivalent to 5 mg/day prednisone

1. A patient who has been enrolled into the OLES and needs to receive an acute bolus
of steroids (oral or injectable) for a self-limited illness may continue treatment in
the study if the following requirements are met:

1. Exposure to steroids will be limited to no more than 30 consecutive days

2. The maximal dose of steroid (prednisone equivalent) must be limited to no more
than 225 mg (7.5 mg each day for 30 days)

3. The illness is acute in nature and is not expected to recur during the remaining
period of the study

- Bisphosphonates, including investigational bisphosphonates

- Calcitonin

- Estrogen replacement therapy by oral, transdermal or intramuscular
administration

- SERM drugs, e.g., tamoxifen, raloxifene, Evista

- Vaginal application of estrogen-containing creams unless the dose is:

1. conjugated estrogen or estradiol: maximum of 0.5 g twice each week
(total of 1.0 g weekly)

2. Estrace (Ogen): maximum of 1.0 g twice each week (total of 2.0 g
weekly)

- Daily inhaled corticosteroid unless dose is equivalent to <1200 µg/day of
beclomethasone

- Cytostatics, e.g., azathioprine, recombinant human tumor necrosis fusion
(Fc) protein, monoclonal antibody against tumor necrosis factor (e.g.,
remicade [infliximab]

- Methotrexate

1. The antimetabolite, methotrexate, which interferes with DNA synthesis,
repair and cellular replication should not be used by patients
participating in this OLES.

- In general, immunomodulatory agents with antiproliferative activity are not
permitted as a concomitant medication in this OLES.

- Intra-articular injections

1. Patients may receive a maximum of one intra-articular injection (ONE
JOINT ONLY) every 6 months while participating in this OLES. The joint that
is injected may be a different joint every 6 months. The dose of
corticosteroid injected should not exceed the anti-inflammatory equivalent
dose of Prednisone 40 mg suspension. The dose and volume should be adjusted
downward as appropriate to the size of the joint.

- Provera is an acceptable concomitant medication when used according to the
label instructions

Patients may be enrolled in this OLES if they have been stabilized on the
following therapy for the specified amount of time:

- Thyroid Hormone (<0.1 mg/day thyroxine) therapy for at least 6 months If
taking > 0.1 mg/day but < 0.2 mg/day, must have serum TSH level 1. >
0.1mU/L. Patients will be excluded if they are taking doses of > 0.2
mg/day.

2. However, if a patient has had a minimal change in L-thyroxine dose of <
0.025 mg/day within 6 months of the baseline visit, and has been on this
new dose for at least 2 months, the patient may be enrolled in this study.
The patient's history with L-thyroxine must be clearly documented in the
source documents.

3. If a patient requires an increase in their thyroid replacement dose, as
recommended by a physician who is caring for the patient, after enrollment
in this OLES, the patient must have a TSH and T4 level within 3 months of
the dose change to ensure the patient does not become hyperthyroid

- Stable dosage of thiazide for at least 3 consecutive months

C. Laboratory Values and Physical Examination Findings:

- Serum calcium greater than 10.7 mg/dL (2.66 mmol/L) at baseline will be
managed as outlined in Appendix 4

- Urinary calcium to creatinine ratio greater than or equal to 1 at baseline
will be managed as outlined in Appendix 5

- Elevated total serum alkaline phosphates (> 400 U/L) at baseline will be
managed as outlined in Appendix 6 except as noted for Latin and South
American countries.

- Any other clinically significant abnormal value as judged by the
investigator

D. Substance Abuse:

Alcohol and/or drug abuse

E. Compliance:

Suspected or confirmed poor compliance in completing clinical trial evaluations
and/or clinical trial required questionnaires
We found this trial at
85
sites
Palm Harbor, Florida 34684
?
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
1925 W. Mountain View Ave.
Longmont, Colorado 80501
303-776-8718
?
mi
from
Longmont, CO
Click here to add this to my saved trials
593 Eddy Street
Providence, Rhode Island 02903
401-444-4000
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
?
mi
from
Providence, RI
Click here to add this to my saved trials
8122 Datapoint Drive
San Antonio, Texas 78229
210-614-7483
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
1897 Palm Beach Lakes Boulevard
West Palm Beach, Florida 33409
561-689-0606
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Albuquerque, New Mexico 87108
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Anderson, South Carolina 29621
?
mi
from
Anderson, SC
Click here to add this to my saved trials
?
mi
from
Bangor, ME
Click here to add this to my saved trials
Bethesda, Maryland 20817
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Bismarck, North Dakota 58501
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
Boca Raton, Florida
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Boise, Idaho 83702
?
mi
from
Boise, ID
Click here to add this to my saved trials
Buenos Aires, BUE
?
mi
from
Buenos Aires,
Click here to add this to my saved trials
?
mi
from
Burlington, VT
Click here to add this to my saved trials
Chattanooga, Tennessee 37421
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Columbia, South Carolina 29204
?
mi
from
Columbia, SC
Click here to add this to my saved trials
Concord, California
?
mi
from
Concord, CA
Click here to add this to my saved trials
?
mi
from
Concord, NH
Click here to add this to my saved trials
?
mi
from
Cumberland, MD
Click here to add this to my saved trials
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
Detroit, Michigan 48236
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
?
mi
from
Duncansville, PA
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Fargo, North Dakota 58103
?
mi
from
Fargo, ND
Click here to add this to my saved trials
?
mi
from
Frederick, MD
Click here to add this to my saved trials
Grand Forks, North Dakota 58201
?
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Greer, South Carolina
?
mi
from
Greer, SC
Click here to add this to my saved trials
Hamden, Connecticut 06518
?
mi
from
Hamden, CT
Click here to add this to my saved trials
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
Honolulu, Hawaii 96814
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
Houston, Texas 77024
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Huntsville, AL
Click here to add this to my saved trials
Indianapolis, Indiana 46202
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Inverness, Florida 34452
?
mi
from
Inverness, FL
Click here to add this to my saved trials
Loma Linda, California 92354
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials
?
mi
from
Madison, WI
Click here to add this to my saved trials
Mayfield Village, Ohio 44143
?
mi
from
Mayfield Village, OH
Click here to add this to my saved trials
Medford, Oregon 97504
?
mi
from
Medford, OR
Click here to add this to my saved trials
Midland, Texas 79705
?
mi
from
Midland, TX
Click here to add this to my saved trials
8701 W Watertown Plank Rd
Milwaukee, Wisconsin
(414) 955-8296
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Minot, North Dakota 58701
?
mi
from
Minot, ND
Click here to add this to my saved trials
New Orleans, Louisiana 70121
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Newport News, Virginia 23606
?
mi
from
Newport News, VA
Click here to add this to my saved trials
Oakland, California 94612
?
mi
from
Oakland, CA
Click here to add this to my saved trials
Ocala, Florida 34471
?
mi
from
Ocala, FL
Click here to add this to my saved trials
Olive Branch, Mississippi 38654
?
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Palm Desert, California 92260
?
mi
from
Palm Desert, CA
Click here to add this to my saved trials
3801 Miranda Avenue
Palo Alto, California 94304
650-493-5000
VA Palo Alto Health Care System The VA Palo Alto Health Care System (VAPAHCS) consists...
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
1020 Walnut St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85013
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
200 Lothrop St
Pittsburgh, Pennsylvania 15213
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Providence, Rhode Island 02908
?
mi
from
Providence, RI
Click here to add this to my saved trials
Rancho Cucamonga, California 91730
?
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Rapid City, South Dakota 57701
?
mi
from
Rapid City, SD
Click here to add this to my saved trials
Richmond, Virginia 23294
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Richmond, Virginia 23298
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Rochester, New York 14609
?
mi
from
Rochester, NY
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
san Diego, California 92120
?
mi
from
san Diego, CA
Click here to add this to my saved trials
San Diego, California 92108
?
mi
from
San Diego, CA
Click here to add this to my saved trials
1001 Potrero Ave
San Francisco, California 94110
(415) 206-8000
San Francisco General Hospital San Francisco General Hospital and Trauma Center (SFGH) is an essential...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Sandy, Utah 84070
?
mi
from
Sandy, UT
Click here to add this to my saved trials
Seattle, Washington 98105
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Sioux Falls, South Dakota 57105
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
?
mi
from
South Miami, FL
Click here to add this to my saved trials
South Plainfield, New Jersey 07080
?
mi
from
South Plainfield, NJ
Click here to add this to my saved trials
Springfield, Missouri 65807
?
mi
from
Springfield, MO
Click here to add this to my saved trials
Stony Brook, New York 11794
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
?
mi
from
Stuart, FL
Click here to add this to my saved trials
?
mi
from
Tulsa, OK
Click here to add this to my saved trials
Watertown, South Dakota 57201
?
mi
from
Watertown, SD
Click here to add this to my saved trials
West Reading, Pennsylvania 19611
?
mi
from
West Reading, PA
Click here to add this to my saved trials
?
mi
from
Wheaton, MD
Click here to add this to my saved trials
White Plains, New York 10605
?
mi
from
White Plains, NY
Click here to add this to my saved trials
Wichita, Kansas 67208
?
mi
from
Wichita, KS
Click here to add this to my saved trials
Wyomissing, Pennsylvania 19610
?
mi
from
Wyomissing, PA
Click here to add this to my saved trials